Accelerating Drug Discovery with a 2nd Year Alliance
Eurofins Discovery, a major player in drug discovery research, has recently announced the renewal of its collaboration with Dompé farmaceutici S.p.A. based in Italy. This partnership focuses on utilizing Dompé’s powerful AI platform to expedite the identification of new therapeutics, marking the second year of their successful alliance.
The collaboration leverages Eurofins Discovery’s comprehensive DiscoveryOne™ Integrated Drug Discovery capabilities with Dompé’s sophisticated supercomputing AI platform. By combining their strengths, Eurofins Discovery and Dompé are at the forefront of advancing drug discovery for companies utilizing internal AI platforms.
Eurofins Discovery brings to the table a wide range of capabilities, including optimized screening cascades, automated chemical synthesis, and top-quality data generation. Their proven expertise in novel biology and vast portfolio of assays make them a valuable partner in this collaborative effort.
On the other hand, Dompé contributes its Exscalate supercomputing and AI data analytics, offering a virtual screening platform capable of evaluating trillions of molecules for each new target. Together, Eurofins Discovery and Dompé are poised to revolutionize the discovery of novel molecules and accelerate research that can ultimately benefit human health.
About Eurofins Discovery
Eurofins Discovery has been a leader in drug discovery research for over 40 years, offering a wide range of products and services to support research efforts. With a portfolio of over 23,000 solutions, Eurofins Discovery is dedicated to transforming drug discovery processes.
About Dompé farmaceutici
Dompé is a renowned biopharmaceutical company with 130 years of experience in life sciences. Based in Milan, Italy, with operations in Boston and San Francisco, Dompé is committed to utilizing cutting-edge tools like the Exscalate platform for intelligent supercomputing drug discovery.
For more information, visit businesswire.com
Media Contact:
Aida Yodites, Director, Marketing Communications
aida.yodites@discovery.eurofinsus.com
Source: Eurofins